81 related articles for article (PubMed ID: 1520028)
1. Successful use of Orthoclone OKT 3 for steroid-resistant acute rejection in pediatric renal allograft recipients.
Palmer J; Slook P
ANNA J; 1992 Aug; 19(4):375-7. PubMed ID: 1520028
[TBL] [Abstract][Full Text] [Related]
2. OKT 3: nursing considerations for use in acute renal transplant rejection.
Trusler LA
ANNA J; 1990 Aug; 17(4):299-303. PubMed ID: 2118750
[TBL] [Abstract][Full Text] [Related]
3. Muromonab-CD3 and antithymocyte globulin in renal transplantation.
Burk ML; Matuszewski KA
Ann Pharmacother; 1997 Nov; 31(11):1370-7. PubMed ID: 9391693
[TBL] [Abstract][Full Text] [Related]
4. [OKT 3 treatment of kidney transplant recipients].
Zlabinger GJ; Ulrich W; Pohanka E; Kovarik J
Wien Klin Wochenschr; 1990 Mar; 102(5):142-7. PubMed ID: 2108521
[TBL] [Abstract][Full Text] [Related]
5. [Pentamidine inhalation in prevention of pneumocystis carinii pneumonia in treatment of rejection with monoclonal antibody Orthoclone (OKT-3)].
Barenbrock M; Spieker C; Buchholz B; Zidek W; Rahn KH
Med Klin (Munich); 1992 Oct; 87 Suppl 1():53-5. PubMed ID: 1461229
[TBL] [Abstract][Full Text] [Related]
6. [Use of OKT-3 in treatment of rejection following kidney transplantation].
Hansen C; Müller P; Seibt F; Oesterwitz H; May G; Strobelt V; Kaden J; Ditscherlein G; Scholz D
Z Urol Nephrol; 1990 Apr; 83(4):165-70. PubMed ID: 2116055
[TBL] [Abstract][Full Text] [Related]
7. Nursing care of patients receiving orthoclone OKT 3.
Moir EJ
ANNA J; 1989 Aug; 16(5):327-8, 366. PubMed ID: 2505696
[TBL] [Abstract][Full Text] [Related]
8. Comparison of adjusted-dose vs standard-dose OKT3 therapy of acute rejection in pediatric kidney transplant recipients.
Piatosa B; Grenda R; Prokurat S
Transplant Proc; 1993 Aug; 25(4):2574. PubMed ID: 8356675
[No Abstract] [Full Text] [Related]
9. [Treatment of kidney graft rejection with a monoclonal antibody (Orthoclone OKT-3)].
Ladefoged SD; Friedberg M; Glenthøj A
Ugeskr Laeger; 1988 Nov; 150(48):2974-6. PubMed ID: 3144080
[No Abstract] [Full Text] [Related]
10. Cardiovascular side effects after renal allograft rejection therapy with Orthoclone: prevention with nitrendipine.
Spieker C; Zidek W; Barenbrock M; Sprakel B; Buchholz B; Rahn KH
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S79-81. PubMed ID: 1723464
[TBL] [Abstract][Full Text] [Related]
11. Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation.
Hooks MA; Wade CS; Millikan WJ
Pharmacotherapy; 1991; 11(1):26-37. PubMed ID: 1902291
[TBL] [Abstract][Full Text] [Related]
12. [Neurologic complications induced by the treatment of the acute renal allograft rejection with the monoclonal antibody OKT3].
Fernández O; Romero F; Bravo M; Burgos D; Cabello M; González-Molina M
Neurologia; 1993 Oct; 8(8):277-80. PubMed ID: 8240843
[TBL] [Abstract][Full Text] [Related]
13. [Orthoclone OKT3 in the treatment of intractable acute renal allograft rejection].
Yu LX
Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):754-5. PubMed ID: 8033708
[TBL] [Abstract][Full Text] [Related]
14. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
McLigeyo SO; Notghi A; Anderton JL; Dick J
East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of invasive cytomegalovirus disease with administration of muromonab CD-3 in patients undergoing orthotopic liver transplantation.
Hooks MA; Perlino CA; Henderson JM; Millikan WJ; Kutner MH
Ann Pharmacother; 1992 May; 26(5):617-20. PubMed ID: 1317228
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
[No Abstract] [Full Text] [Related]
17. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
[TBL] [Abstract][Full Text] [Related]
18. Nursing guidelines for muromonab-CD3 (OKT3).
Duffy MM; Nestor A
ANNA J; 1992 Oct; 19(5):493-5. PubMed ID: 1456797
[TBL] [Abstract][Full Text] [Related]
19. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
Tvedegaard E; Olgaard K
Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
[No Abstract] [Full Text] [Related]
20. Induction therapy with OKT3 in pediatric liver-transplant recipients.
Ryckman FC; Schroeder TJ; Pedersen SH; Dittrich VS; Balistreri WF
Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
